Apar Kishor Ganti, M.D.

Apar Kishor Ganti, MD

Apar Kishor Ganti, M.D.
Professor Internal Medicine
Division of Oncology & Hematology

Academic office mailing address:
UNMC Oncology/Hematology Division
986840 Nebraska Medical Center
Omaha, NE 681980-6840

Main Academic Ph. 402-559-8500
New Patient Referral Ph. 402-559-5600
Fax. 402-559-6520

Practice location:
Fred & Pamela Buffett Cancer Center
505 South 45th Street
Omaha, NE 68105 (map)

B.J. Medical College, University of Pune, India, Medical School, 1990-1996
B.J. Medical College, University of Pune, India, Residency (Clinical Pharmacology), 1996-1999
University of North Dakota School of Medicine, Fargo, ND, Internship, 2000-2001
University of North Dakota School of Medicine, Fargo, ND, Residency (Internal Medicine), 2001-2003
University of Nebraska Medical Center, Omaha, NE, Fellowship, (Oncology/Hematology), 2003-2005

Hospital Appointments:
Nebraska Medicine
VA Nebraska-Western Iowa Health Care System

Lung, Head and Neck Cancers

Biographical Sketch:
Dr. Apar Kishor Ganti is an Associate Professor in the Department of Internal Medicine, Division of Oncology/Hematology, at the University of Nebraska Medical Center. He received his medical degree in 1996 from B.J. Medical College, University of Pune, India, and served a residency in Clinical Pharmacology at B.J. Medical College, University of Pune, from 1996-1999. Dr. Ganti completed his Internship (2000 to 2001) in Internal Medicine Residency (2001 to 2003), at the University of North Dakota School of Medicine in Fargo, ND. From 2003-2005, Dr. Ganti was an oncology/hematology fellow at the University of Nebraska Medical Center, in Omaha, NE

Currently, Dr. Ganti is actively engaged in medical practice, teaching and clinical research, and specializes in the care of patients with lung cancer and head and neck cancer at the University of Nebraska Medical Center, Department of Medicine, Oncology/Hematology Division.
Dr. Ganti is certified by the American Board of Internal Medicine (2003), and received the University of Nebraska Medical Center's Internal Medicine Fellowship Research Award in 2005. Dr. Ganti is also a member of the Alpha Omega Alpha Medical Honor Society

Select Publications:
Chadha AS, Ganti AK, Sohi JS, Sahmoun AE, Mehdi SA. Survival in untreated early stage non-small cell lung cancer. Anticancer Res 2005; 3517-20.

Ganti AK, Sahmoun AE, Panwalkar AW, Tendulkar KK, Potti A. Hormone replacement therapy is associated with decreased survival in women with lung cancer. J Clin Oncol 2006; 24:59-63.

Ganti AK, Weisenburger DD, Smith LM, Hans CP, Bociek RG, Bierman PJ, Vose JM, Armitage JO. Patients with grade 3 follicular lymphoma have prolonged relapse-free survival following anthracycline-based chemotherapy: the Nebraska Lymphoma Study Group Experience. Ann Oncol. 2006 Jun; 17(6)920-7. Epub 2006 Mar 8

Ganti AK, Lee SJ, Vose JM, Devetten MP, Bociek RG, Armitage JO, Bierman PJ, Maness LJ, Reed EC, Loberiza FR Jr. Outcomes after hematopoietic stem-cell transplantation for hematologic malignancies in patients with or without advance care planning. J Clin Oncol. 2007 Dec 10; 25(35):5643-8

Ganti AK, Loberiza FR Jr, Kessinger A. Association of positive family history with survival of patients with lung cancer. Lung Cancer. 2009 Jan; 63(1):136-9. Epub 2008 Jun 24

Azim HA Jr, Elattar I, Loberiza FR Jr, Azim H, Mok T, Ganti AK. Third generation triplet cytotoxic chemotherapy in advanced non-small cell lung cancer: a systematic overview.

Avery EJ, Kessinger A, Ganti AK. Therapeutic options for elderly patients with advanced non-small cell lung cancer. Cancer Treat Rev. 2009 Jan

Huang CH, Wick JA, Sittampalam GS, Nirmalanandhan VS, Ganti AK, Neupane PC, Williamson SK, Godwin AK, Schmitt S, Smart NJ, Spencer S, Van Veldhuizen PJ.  A multicenter pilot study examining the role of circulating tumor cells as a blood-based tumor marker in patients with extensive small-cell lung cancer. Front. Oncol. 2014; 4:271.doi: 10.3389/fonc.2014.00271

Bhatt VR, Batra R, Silberstein PT, Loberiza FR Jr, Ganti AK. Effect of smoking on survival from non –small cell lung cancer: a retrospective Veterans’ Affairs Central Cancer Registry (VACCR) cohort analysis. Med Oncol. 2015Jan; 32(1):339.

Ganti AK, Williams CD, Gajra A, Kelley MJ. Effect of age on the efficacy of adjuvant chemotherapy for resected non-small cell lung cancer. Cancer. 2015 Apr 14. Doi:10.1005/cncr.29360. [Epub ahead of print]

Additional Publications at PubMed.Gov: https://www.ncbi.nlm.nih.gov/pubmed